Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crow's Feet
Authors:
- 1 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 35 (10) , 1478-1486
Abstract
Botulinum toxin type A (BoNT-A) is frequently used to treat crow's feet; the optimal dose for each toxin preparation should be established. To compare the efficacy and safety of three doses of BoNT-A with placebo to treat crow's feet. Subjects with moderate to severe crow's feet at maximum smile (mild to severe at rest) were randomized to a single bilateral BoNT-A treatment (15, 30, or 45 U) or placebo. Outcome measures included evaluation of crow's feet by an independent panel from blinded photographs at maximum smile, investigator assessment, and patient satisfaction. Independent panel assessments (Week 4) showed that all BoNT-A doses resulted in significant improvements in crow's feet severity at maximum smile (p<.001); a clear dose-response effect was seen. Improvement over placebo was seen in the 30-U and 45-U groups to Week 12. Investigator assessment showed significant improvement for all doses for 12 weeks at maximum smile and rest (p< or =.01). Patient satisfaction was significantly greater for all doses than for placebo for 16 weeks (all p<.05). All doses were well tolerated. CONCLUSION BoNT-A (15, 30, or 45 U) is an effective and safe treatment for mild to severe crow's feet.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy and Safety of 3- and 5-Injection Patterns (30 and 50 U) of Botulinum Toxin A (Dysport) for the Treatment of Wrinkles in the Glabella and the Central Forehead RegionArchives of Dermatology, 2006
- Botulinum toxin A in the treatment of glabellar lines: Scheduling the next injectionAesthetic Surgery Journal, 2005
- Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crowʼs FeetDermatologic Surgery, 2005
- Toxine botulique et rides : peu d’effets secondaires, et des associations thérapeutiques performantesAnnales de Chirurgie Plastique Esthétique, 2004
- A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar linesJournal of the American Academy of Dermatology, 2004
- Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feetJournal of the American Academy of Dermatology, 2002
- Botulinum toxin A in the therapy of mimic facial linesClinical and Experimental Dermatology, 2001
- Botulinum toxin type A: History and current cosmetic use in the upper faceSeminars in Cutaneous Medicine and Surgery, 2001
- Multiple Testings: Multiple Comparisons and Multiple EndpointsDrug Information Journal, 1998
- Botulinum Toxin A: A Novel Method to Remove Periorbital WrinklesFacial Plastic Surgery, 1994